Gilgamesh Pharma Inc.

Pharmaceuticals · NEW YORK, NY

PharmaceuticalsSEC Form D

Gilgamesh Pharma Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 24, 2026, reporting $60,000,000 raised.

Incorporated in Delaware and based in NEW YORK, NY, it operates in the Pharmaceuticals sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Gilgamesh Pharma Inc. has raised capital from private investors.

Browse more recently funded companies in Pharmaceuticals.

Executives & Directors

  • Jonathan SpornExecutive Officer · Director
  • Andrew KruegelExecutive Officer · Director
  • Zia HuqueDirector
  • Amy KruseDirector
  • Robert BermanDirector
  • Phil SkolnickDirector

Recently funded in Pharmaceuticals

Other companies that recently filed a Form D

$3.0MRaised

FibroBiologics, Inc.

PharmaceuticalsHOUSTON, TX
Jun 25, 2026View SEC Form D
$200.0KRaised

Balsam Pharmaceuticals Co

PharmaceuticalsMCLEAN, VA
Jun 10, 2026View SEC Form D
$750.0KRaised

Eos SENOLYTIX, Inc.

PharmaceuticalsHOUSTON, TX
Jun 4, 2026View SEC Form D
$1.9MRaised

Liminatus Pharma, Inc.

PharmaceuticalsFULLERTON, CA
Jun 3, 2026View SEC Form D
$384.8KRaised

Spine BioPharma, Inc.

PharmaceuticalsNEW YORK, NY
May 22, 2026View SEC Form D